Podcast
Questions and Answers
Which type of diabetes is primarily characterized by insulin resistance in cells?
Which type of diabetes is primarily characterized by insulin resistance in cells?
- Type 1 diabetes mellitus
- Type 2 diabetes mellitus (correct)
- LADA (latent autoimmune diabetes in adults)
- Gestational diabetes
Which of the following is a GLP receptor agonist used in the treatment of diabetes?
Which of the following is a GLP receptor agonist used in the treatment of diabetes?
- Exenatide (correct)
- Metformin
- Canagliflozin
- Pramlintide
Which combination of drugs was the first triple combination of oral anti-diabetics approved in 2019?
Which combination of drugs was the first triple combination of oral anti-diabetics approved in 2019?
- Insulin, metformin, and exenatide
- Pramlintide, canagliflozin, and liraglutide
- Exenatide, pioglitazone, and sitagliptin
- Metformin, saxagliptin, and dapagliflozin (correct)
What is the primary treatment for diabetes mellitus type 1 due to the lack of insulin?
What is the primary treatment for diabetes mellitus type 1 due to the lack of insulin?
What is the main characteristic of oral hypoglycemic agents?
What is the main characteristic of oral hypoglycemic agents?
Flashcards
Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
A type of diabetes primarily characterized by insulin resistance in cells.
Exenatide
Exenatide
A GLP receptor agonist used in the treatment of diabetes.
First Triple Combination Approved (2019)
First Triple Combination Approved (2019)
Combination of Metformin, saxagliptin, and dapagliflozin for diabetes treatment.
Insulin (Type 1 Diabetes Treatment)
Insulin (Type 1 Diabetes Treatment)
Signup and view all the flashcards
Oral Hypoglycemic Agents
Oral Hypoglycemic Agents
Signup and view all the flashcards
Study Notes
Diabetes Characteristics
- Type 2 diabetes is primarily characterized by insulin resistance in cells.
Diabetes Treatment
- Exenatide is a GLP receptor agonist used in the treatment of diabetes.
- The first triple combination of oral anti-diabetics approved in 2019 was Glyburide, Metformin, and Pioglitazone.
Diabetes Mellitus Type 1
- The primary treatment for diabetes mellitus type 1 is insulin replacement due to the lack of insulin.
Oral Hypoglycemic Agents
- The main characteristic of oral hypoglycemic agents is that they stimulate insulin release from the pancreas or increase the sensitivity of insulin receptors.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Test your knowledge of anti-diabetic drugs with this quiz. Explore different drug classes and their mechanisms of action in treating diabetes mellitus, including oral hypoglycemic agents and GLP receptor agonists. See how well you understand the options available for managing blood glucose levels in diabetes.
